A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Clinical trial NCT01439347 · TERMINATED
Trial details
- NCT number
- NCT01439347
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2015-11-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.